Entrada Therapeutics, Inc.

TRDA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$5.11+12.56%

2026-11-02

Financials

Valuation Metrics

Entrada Therapeutics, Inc.'s Market Cap is $198M. At end of 2025 it was $425M. Ranked #3005 of 3,118 in US market (top 96%), #1379 of 1,474 on NASDAQ (top 94%), #250 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 94%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$198M	US#3,005/3,118 Sec#250/265
Revenue	$5M	US#2,821/3,118 Sec#177/265
Net Income	$-166M	US—/3,118 Sec—/265
Total Assets	$299M	US#2,905/3,118 Sec#207/265
Net Assets	$233M	US#2,615/3,118 Sec#174/265
Value
P/B	0.85x	US#221/3,118 Sec#11/265
P/S	42.33x	US#2,902/3,118 Sec#160/265
FCF Yield	-67.73%	US—/3,118 Sec—/265
Profitability
ROE	-71.02%	US#2,745/3,118 Sec#189/265
ROA	-55.47%	US#2,999/3,118 Sec#224/265
Op. Margin	-3767.07%	US#2,823/3,118 Sec#173/265
Revenue Growth	-94.10%	US#2,721/3,118 Sec#179/265
Financial Health
Debt Ratio	28.05%	US#308/3,118 Sec#98/265
Total Debt	$49M	US#2,604/3,118 Sec#154/265
FCF	$-134M	US#2,694/3,118 Sec#168/265
Cash	$99M	US#2,232/3,118 Sec#174/265
Current Ratio	10.89x	US#221/3,118 Sec#69/265
Performance
1Y Return	-26.47%	US#2,660/3,118 Sec#215/265
1M Return	-5.02%	US#2,961/3,118 Sec#247/265
From 52W High	-68.94%	US#2,995/3,118 Sec#242/265
1Y MDD	-72.74%	US#2,967/3,118 Sec#237/265
Trading
Volume	650,991 shares	US#2,481/3,118 Sec#237/265
Trading Value	$3M	US#2,981/3,118 Sec#254/265
Per Share
EPS	$-4.27	US—/3,118 Sec—/265
BPS	$6.01	US#2,188/3,118 Sec#110/265